In addition, Feng found bevacizumab could down-regulate the expression of α-SMA and TGF-β1, block the effect of VEGF on HSCs to reduce liver fibrosis and protect liver function [96]. The gene discussed is VEGFA; the disease is Hepatic fibrosis.